Feline Asthma: Advanced Welfare Management

Key Welfare Considerations

• Feline asthma involves eosinophilic airway inflammation causing bronchoconstriction and mucus hypersecretion.
• Clinical signs range from occasional coughing to life-threatening respiratory distress welfare emergencies.
• The classic asthma posture — crouched with neck extended and elbows out — indicates active respiratory welfare distress.
• Distinguishing asthma from bronchitis, heart disease, and lungworm is essential for welfare-appropriate treatment.
• Inhaled corticosteroids via AeroKat spacer device provide local anti-inflammatory welfare benefit with reduced systemic effects.
• Systemic corticosteroids (prednisolone) are effective but long-term use risks diabetes, obesity, and infection welfare impacts.
• Bronchodilators including salbutamol provide emergency relief of bronchoconstriction welfare during acute attacks.
• Environmental trigger identification and reduction is central to welfare management — including aerosols, dusty litters, and smoke.
• Dust-free, unscented litter significantly reduces airway irritant welfare exposure for asthmatic cats.
• Omega-3 fatty acid supplementation may reduce airway inflammation welfare burden.
• Annual or twice-yearly radiographic monitoring assesses disease progression for welfare-guided treatment adjustment.
• Acute asthma attacks requiring emergency treatment represent critical welfare intervention points.
• Owner training in recognising respiratory distress and emergency drug administration improves welfare outcomes.
• Stress reduction is important — anxiety triggers bronchoconstriction, worsening welfare in asthmatic cats.
• Well-managed feline asthma allows cats to maintain good quality of life despite the chronic nature of the condition.